These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6768093)

  • 1. Modification of different morphine actions by 6-hydroxydopamine and 6-hydroxydopamine plus desmethylimipramine.
    Fuchs V; Coper H
    Psychopharmacology (Berl); 1980 Feb; 67(2):181-8. PubMed ID: 6768093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdalar noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior.
    Lénárd L; Hahn Z
    Brain Res; 1982 Feb; 233(1):115-32. PubMed ID: 6800562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of p-chlorophenylalanine on different morphine effects.
    Fuchs V; Coper H
    Drug Alcohol Depend; 1980 May; 5(5):367-77. PubMed ID: 6445258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-induced behavioral disruption in rats chronically depleted of brain dopamine.
    Kallman MJ; Spencer RM; White AT; Chance WT; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):115-25. PubMed ID: 571130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
    Feigenbaum JJ; Yanai J
    Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
    Pappas B; Ings R; Roberts D
    Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.
    Sarkar DK; Smith GC; Fink G
    Brain Res; 1981 Jun; 213(2):335-49. PubMed ID: 6113874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desmethylimipramine on norepinephrine content and plasticity of kitten visual cortex.
    Allen EE; Blakemore LJ; Trombley PQ; Gordon B
    Brain Res; 1987 Jan; 401(2):397-400. PubMed ID: 3101982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine release by intracerebral perfusion of 6-hydroxydopamine and desipramine.
    Martin GE; Myers RD; Newberg DC
    Eur J Pharmacol; 1976 Apr; 36(2):299-311. PubMed ID: 1278225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of morphine tolerance and physical dependence in rats depleted of brain catecholamines by 6-hydroxydopamine.
    Elchisak MA; Rosecrans JA
    Neuropharmacology; 1979 Feb; 18(2):175-82. PubMed ID: 571053
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H; McRae-Degueurce A
    Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.